GlaxoSmithKline Pharmaceuticals (India) Probability of Future Stock Price Finishing Under 2429.0
| GLAXO Stock | 2,444 30.80 1.28% |
GlaxoSmithKline |
GlaxoSmithKline Pharmaceuticals Target Price Odds to finish below 2429.0
The tendency of GlaxoSmithKline Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 2,429 or more in 90 days |
| 2,444 | 90 days | 2,429 | about 5.45 |
Based on a normal probability distribution, the odds of GlaxoSmithKline Pharmaceuticals to drop to 2,429 or more in 90 days from now is about 5.45 (This GlaxoSmithKline Pharmaceuticals Limited probability density function shows the probability of GlaxoSmithKline Stock to fall within a particular range of prices over 90 days) . Probability of GlaxoSmithKline Pharmaceuticals price to stay between 2,429 and its current price of 2444.4 at the end of the 90-day period is about 1.33 .
Assuming the 90 days trading horizon GlaxoSmithKline Pharmaceuticals has a beta of 0.41. This usually indicates as returns on the market go up, GlaxoSmithKline Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding GlaxoSmithKline Pharmaceuticals Limited will be expected to be much smaller as well. Additionally GlaxoSmithKline Pharmaceuticals Limited has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. GlaxoSmithKline Pharmaceuticals Price Density |
| Price |
Predictive Modules for GlaxoSmithKline Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GlaxoSmithKline Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.GlaxoSmithKline Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. GlaxoSmithKline Pharmaceuticals is not an exception. The market had few large corrections towards the GlaxoSmithKline Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold GlaxoSmithKline Pharmaceuticals Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of GlaxoSmithKline Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.25 | |
β | Beta against Dow Jones | 0.41 | |
σ | Overall volatility | 140.32 | |
Ir | Information ratio | -0.19 |
GlaxoSmithKline Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of GlaxoSmithKline Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for GlaxoSmithKline Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| GlaxoSmithKline Pharmaceuticals generated a negative expected return over the last 90 days | |
| About 76.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: GlaxoSmithKline Pharmaceuticals - Negative Breakout 5 stocks cross below their 200 DMAs - The Economic Times |
GlaxoSmithKline Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of GlaxoSmithKline Stock often depends not only on the future outlook of the current and potential GlaxoSmithKline Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GlaxoSmithKline Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 169.4 M | |
| Cash And Short Term Investments | 18.6 B |
GlaxoSmithKline Pharmaceuticals Technical Analysis
GlaxoSmithKline Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. GlaxoSmithKline Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of GlaxoSmithKline Pharmaceuticals Limited. In general, you should focus on analyzing GlaxoSmithKline Stock price patterns and their correlations with different microeconomic environments and drivers.
GlaxoSmithKline Pharmaceuticals Predictive Forecast Models
GlaxoSmithKline Pharmaceuticals' time-series forecasting models is one of many GlaxoSmithKline Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary GlaxoSmithKline Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about GlaxoSmithKline Pharmaceuticals
Checking the ongoing alerts about GlaxoSmithKline Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for GlaxoSmithKline Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| GlaxoSmithKline Pharmaceuticals generated a negative expected return over the last 90 days | |
| About 76.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: GlaxoSmithKline Pharmaceuticals - Negative Breakout 5 stocks cross below their 200 DMAs - The Economic Times |
Other Information on Investing in GlaxoSmithKline Stock
GlaxoSmithKline Pharmaceuticals financial ratios help investors to determine whether GlaxoSmithKline Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GlaxoSmithKline with respect to the benefits of owning GlaxoSmithKline Pharmaceuticals security.